Radiation myelopathy following transplantation and radiotherapy for non- Hodgkin's lymphoma

International Journal of Radiation Oncology Biology Physics

Volumn 41, Issue 5, 1998, Pages 1057-1061

  Chao, Michael W T ^a   Wirth, Andrew ^a   Ryan, Gail ^a   MacManus, Michael ^a   Liew, K H ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

Chemotherapy; Radiation myelopathy; Radiotherapy; Transplantation

Indexed keywords

ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CASE REPORT; DOSE RESPONSE; FEMALE; HUMAN; MEDIASTINUM TUMOR; NONHODGKIN LYMPHOMA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RADIATION EXPOSURE; RISK FACTOR; SPINAL CORD DISEASE;

ADULT; BONE MARROW TRANSPLANTATION; FEMALE; HUMANS; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; MEDIASTINAL NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY DOSAGE; REFERENCE VALUES; SPINAL CORD; TIME FACTORS;

EID: 0032528203     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)00107-2     Document Type: Article

References (26)

1. Wang P.Y., Shen W.C., Jan J.S. Magnetic resonance imaging in radiation myelopathy. Am. J. Neuroradiol. 13:1993;1049-1055.
2. Armitage J.O. Treatment of non-Hodgkin's lymphoma. N. Engl. J. Med. 328:1993;1023-1030.
3. Armitage J.O. Bone marrow transplantation. N. Engl. J. Med. 330:1994;827-838.
4. Miles-Prince H., Imrie K., Crump M. The role of intensive therapy and autologous blood and marrow transplantation for chemotherapy sensitive relapsed and primary refractory Non-hodgkin's lymphoma Identification of major prognostic groups . Br. J. Haematol. 92:1996;880-889.
5. Reece D.E., Connors J.M., Spinelli J.J. Intensive therapy with cyclophosphamide, carmustine, etoposide ± cisplatin and autologous bone marrow transplantation for Hodgkin's disease in first relapse after combination therapy. Blood. 83:1994;1193-1199.
6. Stahel R.A., Jost L.M., Pichert G. High dose chemotherapy and autologous bone marrow transplantation for malignant lymphomas. Cancer Treat. Rev. 21:1995;3-32.
7. Philip T., Guglielmi C., Hagenbeek A. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy sensitive non-Hodgkin's lymphoma. N. Engl. J. Med. 333:1995;1540-1545.
8. Gainni A.M., Bregni M., Siena S. High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma. N. Engl. J. Med. 336:1997;1290-1297.
9. Yahalom J. Integrating radiotherapy into bone marrow transplantation programs for Hodgkin's disease. Int. J. Radiat. Oncol. Biol. Phys. 33:1995;525-528.
10. Freedman A.S., Takvorian T., Anderson K.C. Autologous bone marrow transplantation in B cell Non-hodgkin's lymphoma Very low treatment related mortality in 100 patients in sensitive relapse . J. Clin. Oncol. 8:1990;784-791.
11. Peterson F.B., Appelbaum F.R., Hill R. Autologous marrow transplantation for malignant lymphoma A report of 101 cases . J. Clin. Oncol. 8:1990;638-647.
12. Constine L., Brasacchi R., Rapoport A. Radiotherapy to previously involved sites after auto-transplantation for lymphoma and Hodgkin's disease. Proc. Am. Soc. Clin. Oncol. 14:1995;394.
13. Poen J.C., Hoppe R.T., Horning J.C. High dose therapy and autologous bone marrow transplantation for relapsed/refractory Hodgkin's disease The impact of involved field radiation therapy on patterns of failure and survival . Int. J. Radiat. Oncol. Biol. Phys. 36:1996;3-12.
14. Chopra J., Mills W., McMillan A. BEAM chemotherapy and autologous bone marrow transplantation for patients with relapsed or refractory non-Hodgkin's lymphoma. J. Clin. Oncol. 13:1995;588-595.
15. Pezner R.D., Nademanee A., Niland J.C. Involved field radiation therapy for Hodgkin's disease autologous bone marrow transplantation regimens. Radiother. Oncol. 34:1995;23-29.
16. Weaver C.H., Appelbaum F.R., Petersen F.B. High dose cyclophosphamide, carmustine and etoposide followed by autologous bone marrow transplantation in patients with lymphoid malignancies who have received dose limiting radiation therapy. J. Clin. Oncol. 11:1993;1329-1335.
17. Schulthiess H., Stephens L.C. Invited review - permanent radiation myelopathy. Br. J. Radiol. 65:1992;737-753.
18. Chouchair A.K. Myelopathies in the cancer patient Incidence, presentation, diagnosis and management . Oncology. 5:1991;25-37.
19. Feldman E., Posner J.B. Episodic neurologic dysfunction in patients with Hodgkin's disease. Arch. Neurol. 43:1986;1227-1233.
20. Bleyer W.A., Griffin T.W. White matter necrosis, mineralising microangiopathy and intellectual abilities in survivors of childhood leukemia Associations with central nervous system irradiation and methotrexate . Gilbert J.A., Kagan J.R. Radiation damage to the nervous system. 1980;155-174 Raven Press, New York.
21. Walther P.J., Rossitch E., Bullard D.E. The development of L'Hermitt's sign during cisplatin chemotherapy. Cancer. 60:1987;2170-2172.
22. Lee Y.Y., Nauert C., Glass J.P. Treatment related white matter changes in cancer patients. Cancer. 57:1986;1473-1482.
23. Ruckdeschel J.C., Baxter D.H., McKneally M.F. Sequential radiotherapy and adriamycin in the management of bronchogenic carcinoma The question of additive toxicity . Int. J. Radiat. Oncol. Biol. Phys. 5:1979;1323-1328.
24. Duncan J.H., Colvin M.O., Fenselau C. Mass spectrophotometric study of the distribution of cyclophosphamide in humans. Toxicol. Appl. Pharmacol. 24:1973;317-323.
25. Roach M., Madhu J.J., Kallman R.F. Alkylating agents. Madhu J., Flam M.S., Legha S.S. Chemoradiation - an integrated approach to cancer treatment. 1993;90-103 Lea & Febiger.
26. Hartmann O., Benhamou E., Beaujean F. High-dose busulfan and cyclophosphamide with autologous bone marrow transplantation support in advanced malignancies in children A Phase 2 study . J. Clin. Oncol. 4:1986;1804-1810.